Linked Life Data

19855056

Source:http://linkedlifedata.com/resource/pubmed/id/19855056

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19855056rdf:typepubmed:Citationlld:pubmed
pubmed-article:19855056lifeskim:mentionsumls-concept:C0007452lld:lifeskim
pubmed-article:19855056lifeskim:mentionsumls-concept:C1267092lld:lifeskim
pubmed-article:19855056lifeskim:mentionsumls-concept:C0221464lld:lifeskim
pubmed-article:19855056lifeskim:mentionsumls-concept:C1522318lld:lifeskim
pubmed-article:19855056lifeskim:mentionsumls-concept:C0020281lld:lifeskim
pubmed-article:19855056lifeskim:mentionsumls-concept:C0600388lld:lifeskim
pubmed-article:19855056lifeskim:mentionsumls-concept:C0242184lld:lifeskim
pubmed-article:19855056lifeskim:mentionsumls-concept:C0035028lld:lifeskim
pubmed-article:19855056lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:19855056pubmed:issue6lld:pubmed
pubmed-article:19855056pubmed:dateCreated2009-11-25lld:pubmed
pubmed-article:19855056pubmed:abstractTextMitochondrial reactive oxygen species (ROS) are potentially important in vascular oxygen-sensing mechanisms because hypoxia appears to be a stimulus for mitochondrial ROS generation; however, scavenging of endogenous ROS does not alter relaxation of endothelium-denuded bovine coronary arteries (BCA) to hypoxia. The purpose of this study was to investigate the influence of increasing mitochondrial ROS on the relaxation of BCA to hypoxia. Increasing mitochondrial superoxide with inhibitors of electron transport (10 microM rotenone and antimycin) and by opening mitochondrial ATP-dependent K+ channels with 100 microM diazoxide were observed in this study to attenuate relaxation of BCA precontracted with 30 mM KCl to hypoxia by 68-76% and 38%, respectively. This effect of rotenone is not prevented by inhibiting NADPH oxidase (Nox) activation or scavenging superoxide with Peg-SOD; however, it is reversed 85% and 26% by increasing the consumption of intracellular peroxide by 0.1 mM ebselen and 32.5 U/ml Peg-catalase. Because inhibition of extracellular signal-regulated kinase (ERK) mitogen-activated protein (MAP) kinase (10 microM PD-98059), but not src kinase or rho kinase, also reverses the effects of rotenone by 69%, the peroxide-elicited force-enhancing effects of ERK appear to be attenuating the response to hypoxia. Rotenone increased the phosphorylation of ERK (by 163%). Activation of ERK in BCA with 0.1 mM peroxide or endogenous peroxide generated by stimulating Nox2 with a stretch treatment or contraction with 100 nM U-46619 also attenuated relaxation to hypoxia. Thus coronary arterial relaxation to hypoxia may be attenuated by pathophysiological conditions associated with increased peroxide generation by mitochondria or other sources that stimulate ERK.lld:pubmed
pubmed-article:19855056pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19855056pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19855056pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19855056pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19855056pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19855056pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19855056pubmed:languageenglld:pubmed
pubmed-article:19855056pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19855056pubmed:citationSubsetIMlld:pubmed
pubmed-article:19855056pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19855056pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19855056pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19855056pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19855056pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19855056pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19855056pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19855056pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19855056pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19855056pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19855056pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19855056pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19855056pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19855056pubmed:statusMEDLINElld:pubmed
pubmed-article:19855056pubmed:monthDeclld:pubmed
pubmed-article:19855056pubmed:issn1522-1539lld:pubmed
pubmed-article:19855056pubmed:authorpubmed-author:CoxL GLGlld:pubmed
pubmed-article:19855056pubmed:authorpubmed-author:WolinMichael...lld:pubmed
pubmed-article:19855056pubmed:authorpubmed-author:AhmadMansoorMlld:pubmed
pubmed-article:19855056pubmed:authorpubmed-author:ZhaoXiangminXlld:pubmed
pubmed-article:19855056pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19855056pubmed:volume297lld:pubmed
pubmed-article:19855056pubmed:ownerNLMlld:pubmed
pubmed-article:19855056pubmed:authorsCompleteYlld:pubmed
pubmed-article:19855056pubmed:paginationH2262-9lld:pubmed
pubmed-article:19855056pubmed:dateRevised2011-9-13lld:pubmed
pubmed-article:19855056pubmed:meshHeadingpubmed-meshheading:19855056...lld:pubmed
pubmed-article:19855056pubmed:meshHeadingpubmed-meshheading:19855056...lld:pubmed
pubmed-article:19855056pubmed:meshHeadingpubmed-meshheading:19855056...lld:pubmed
pubmed-article:19855056pubmed:meshHeadingpubmed-meshheading:19855056...lld:pubmed
pubmed-article:19855056pubmed:meshHeadingpubmed-meshheading:19855056...lld:pubmed
pubmed-article:19855056pubmed:meshHeadingpubmed-meshheading:19855056...lld:pubmed
pubmed-article:19855056pubmed:meshHeadingpubmed-meshheading:19855056...lld:pubmed
pubmed-article:19855056pubmed:meshHeadingpubmed-meshheading:19855056...lld:pubmed
pubmed-article:19855056pubmed:meshHeadingpubmed-meshheading:19855056...lld:pubmed
pubmed-article:19855056pubmed:meshHeadingpubmed-meshheading:19855056...lld:pubmed
pubmed-article:19855056pubmed:meshHeadingpubmed-meshheading:19855056...lld:pubmed
pubmed-article:19855056pubmed:meshHeadingpubmed-meshheading:19855056...lld:pubmed
pubmed-article:19855056pubmed:meshHeadingpubmed-meshheading:19855056...lld:pubmed
pubmed-article:19855056pubmed:meshHeadingpubmed-meshheading:19855056...lld:pubmed
pubmed-article:19855056pubmed:meshHeadingpubmed-meshheading:19855056...lld:pubmed
pubmed-article:19855056pubmed:meshHeadingpubmed-meshheading:19855056...lld:pubmed
pubmed-article:19855056pubmed:meshHeadingpubmed-meshheading:19855056...lld:pubmed
pubmed-article:19855056pubmed:meshHeadingpubmed-meshheading:19855056...lld:pubmed
pubmed-article:19855056pubmed:meshHeadingpubmed-meshheading:19855056...lld:pubmed
pubmed-article:19855056pubmed:meshHeadingpubmed-meshheading:19855056...lld:pubmed
pubmed-article:19855056pubmed:meshHeadingpubmed-meshheading:19855056...lld:pubmed
pubmed-article:19855056pubmed:meshHeadingpubmed-meshheading:19855056...lld:pubmed
pubmed-article:19855056pubmed:meshHeadingpubmed-meshheading:19855056...lld:pubmed
pubmed-article:19855056pubmed:year2009lld:pubmed
pubmed-article:19855056pubmed:articleTitleMitochondrial-derived hydrogen peroxide inhibits relaxation of bovine coronary arterial smooth muscle to hypoxia through stimulation of ERK MAP kinase.lld:pubmed
pubmed-article:19855056pubmed:affiliationDepartment of Physiology, New York Medical College, Valhalla, NY 10595, USA.lld:pubmed
pubmed-article:19855056pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19855056pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:19855056pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19855056lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19855056lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19855056lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19855056lld:pubmed